v3.26.3
STOCKHOLDERS' EQUITY (DEFICIT) AND MEZZANINE EQUITY - Continuity of RSUs (Details) - Restricted Stock Units
9 Months Ended
Aug. 31, 2026
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Granted (in shares) | shares 592,125
Vested (in shares) | shares (231,751)
Ending balance (in shares) | shares 360,374
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Weighted average exercise price, granted | $ / shares $ 9.31
Weighted average exercise price, vested | $ / shares 9.28
Weighted average exercise price, ending | $ / shares $ 9.32